Prognostic test for E2F4 in breast cancer that will be valuable in other cancers
By looking at the expression levels of downstream genes of the regulators in breast cancer, investigators at Dartmouth Hitchcock’s Norris Cotton Cancer Center (NCCC), led by Chao Cheng, PhD, have identified a gene signature in E2F4 that is predictive of oestrogen receptor positive (ER+) breast cancer. The findings define a new opportunity for personalizing medicine […]
